Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 10-Q (Unaudited)
Period Ended: March 31, 2010
Overview: The Company is the largest publicly traded operator of hospitals in the U.S. by facility count and revenue, operating 122 general acute care hospitals, home care agencies, and management services. The quarter was significantly impacted by the enactment of the Patient Protection and Affordable Care Act (PPACA) and the Reconciliation Act on March 23 and March 30, 2010, respectively.
Key Financial Metrics
| Metric (in thousands) | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Operating Revenues | $3,160,722 | $2,912,749 |
| Income from Operations | $273,012 | $255,038 |
| Net Income (Total) | $84,996 | $72,900 |
| Net Income Attributable to CHS | $70,007 | $58,915 |
| Diluted EPS (Attributable to CHS) | $0.75 | $0.65 |
| Operating Cash Flow | $299,360 | $259,427 |
| Cash and Equivalents (Ending) | $480,066 | $532,132 |
| Total Debt (Current + Long-term) | $8,901,630 | $8,911,108 |
| Working Capital | $1,346,281 | $1,217,199 |
Note: Debt figures derived from Balance Sheet current maturities and long-term debt. Working capital calculated as Current Assets minus Current Liabilities.
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 8.5% ($248.0 million) year-over-year. Growth was driven by acquisitions ($139.2 million) and organic growth from hospitals owned in both periods ($108.8 million). Same-store revenue increased 3.7%.
- Profitability: Net income attributable to CHS increased 18.8% to $70.0 million. Income from continuing operations before taxes rose 17.5% to $125.1 million.
- Expense Trends: Operating expenses as a percentage of revenue increased slightly to 86.7% (from 86.5%). Salaries and benefits rose to 40.6% of revenue, while the provision for bad debts increased to 12.0% due to economic conditions affecting patient ability to pay.
- Interest Expense: Net interest expense decreased $3.4 million (2.1%) to $160.5 million, primarily due to debt repayments made in 2009.
- Cash Flow: Operating cash flow improved by $40.0 million, driven by higher net income and increased accounts payable/accrued liabilities, partially offset by a $76.2 million decrease in cash flow from accounts receivable.
Guidance, Outlook, Risks, and Unusual Items
Legislative Impact (Reform Legislation)
The Company notes that the PPACA and Reconciliation Act will increase insured patients (reducing bad debt) but also impose reimbursement reductions for Medicare/Medicaid (market basket updates, productivity offsets) and increase operating costs (employee health insurance). The Company cannot predict the net impact at this time.
Legal Proceedings
- False Claims Act (New Mexico): The Department of Justice intervened in a qui tam lawsuit alleging improper Medicaid claims by three New Mexico hospitals. The government calculated ineligible payments of approximately $27.5 million (2000-2006) and seeks treble damages. The Company is vigorously defending the action.
- Kyphoplasty Investigation: The U.S. Attorney's Office is investigating billing practices for kyphoplasty procedures at two hospitals. Similar investigations are ongoing at unaffiliated facilities.
- Class Action (Roswell): A putative class action regarding uninsured patients was certified by a state court in April 2010.
Capital Resources
The Company maintains a $7.2 billion Credit Facility with $750 million available under the revolving credit facility (less $101 million for letters of credit). The Company has $310 million in estimated construction costs for three replacement facilities required by purchase agreements.
Investor Verification Checklist
- Reimbursement Rates: Verify the specific impact of the new healthcare reform legislation on the Company's specific payor mix, particularly regarding Medicare market basket reductions.
- Bad Debt Reserves: Monitor the provision for bad debts (12.0% of revenue) given the economic environment and the Company's reliance on self-pay and Medicaid patients.
- Legal Exposure: Assess the potential financial impact of the False Claims Act litigation in New Mexico and the kyphoplasty investigations, including potential treble damages.
- Debt Covenants: Review compliance with leverage and interest coverage ratios under the Credit Facility, especially given the restrictions on dividends and stock repurchases.
- Capital Expenditures: Track progress and costs associated with the required replacement hospital construction in Valparaiso, IN; Siloam Springs, AR; and Barstow, CA.